Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

École Polytechnique de Montréal

$28,000.00

Rational development of fed-batch mammalian cell culture processes

EF 2018-19

Résumé
Mammalian cell culture remains the dominant expression system for the manufacturing of recombinant proteins for clinical applications. With several hundreds of protein products currently in clinical trials and with the anticipated emergence of several blockbuster biosimilars, the biotherapeutics market is expected to grow exponentially within the next decade. For the majority of these novel bioproducts, the capacity to mass produce them in a cost-efficient manner will be a critical factor for their successful translation to the clinic and market.*The central goal of this NSERC Discovery Research Program is to devise innovative strategies that will enable the rapid development of robust and cost-effective cell culture-based manufacturing processes. To better cope with the inherent complexity of mammalian cell cultures, the research will be conducted following a multi-scale system's approach integrating information at the cellular and process levels. More specifically, the research program will aim to i) conduct comprehensive metabolic characterization of mammalian cells under relevant process conditions in order to guide and streamline optimization efforts ii) develop reliable mathematical models linking process conditions and cell culture state in order to simulate and predict process performance and iii) design and implement efficient model-based dynamic fed-batch strategies ensuring high product yield and consistency. *The methodology will be based on advanced and emerging analytical methods, including the use of mass spectrometry analysis and isotopic tracers for conducting metabolic studies and surface plasmon resonance (SPR) for rapid at-line assessment of product bioactivity. The research will primarily target an industrially relevant application, the production of monoclonal antibodies by Chinese Hamster Ovary (CHO) cells, as these cells are the main workhorse of the biopharmaceutical industry. The research will also pursue the development of cell culture processes involving mammalian cells that have been engineered to possess an improved metabolic efficiency. *The novelty of the research program lies not only in its anticipated outcomes, but also in the innovative application of a multi-scale systems approach combining cellular and process engineering strategies for conducting rational process development and generating new knowledge. This research is expected to bring a significant contribution to the development and manufacturing of biotherapeutics, an area of considerable economic importance and having a direct impact on the health and welfare of Canadian citizens. By addressing the needs for improved and efficient bioprocesses, these research efforts can help to reduce the cost and time in getting recombinant products to the clinic and market and will thus ultimately benefit both patients and industry.*
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2016-06407
Name nom
Henry, Olivier
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2016
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
3
Nb partie
5
Application title
Rational development of fed-batch mammalian cell culture processes
Keyword
NSERC
Application summary
Mammalian cell culture remains the dominant expression system for the manufacturing of recombinant proteins for clinical applications. With several hundreds of protein products currently in clinical trials and with the anticipated emergence of several blockbuster biosimilars, the biotherapeutics market is expected to grow exponentially within the next decade. For the majority of these novel bioproducts, the capacity to mass produce them in a cost-efficient manner will be a critical factor for their successful translation to the clinic and market.*The central goal of this NSERC Discovery Research Program is to devise innovative strategies that will enable the rapid development of robust and cost-effective cell culture-based manufacturing processes. To better cope with the inherent complexity of mammalian cell cultures, the research will be conducted following a multi-scale system's approach integrating information at the cellular and process levels. More specifically, the research program will aim to i) conduct comprehensive metabolic characterization of mammalian cells under relevant process conditions in order to guide and streamline optimization efforts ii) develop reliable mathematical models linking process conditions and cell culture state in order to simulate and predict process performance and iii) design and implement efficient model-based dynamic fed-batch strategies ensuring high product yield and consistency. *The methodology will be based on advanced and emerging analytical methods, including the use of mass spectrometry analysis and isotopic tracers for conducting metabolic studies and surface plasmon resonance (SPR) for rapid at-line assessment of product bioactivity. The research will primarily target an industrially relevant application, the production of monoclonal antibodies by Chinese Hamster Ovary (CHO) cells, as these cells are the main workhorse of the biopharmaceutical industry. The research will also pursue the development of cell culture processes involving mammalian cells that have been engineered to possess an improved metabolic efficiency. *The novelty of the research program lies not only in its anticipated outcomes, but also in the innovative application of a multi-scale systems approach combining cellular and process engineering strategies for conducting rational process development and generating new knowledge. This research is expected to bring a significant contribution to the development and manufacturing of biotherapeutics, an area of considerable economic importance and having a direct impact on the health and welfare of Canadian citizens. By addressing the needs for improved and efficient bioprocesses, these research efforts can help to reduce the cost and time in getting recombinant products to the clinic and market and will thus ultimately benefit both patients and industry.*